NIAMS to Fund Small Businesses for Inflammatory Disease Biomarker Tools | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institute of Arthritis and Musculoskeletal and Skin Diseases seeks to support small businesses that are developing potential biomarker platforms to predict the onset and progression of inflammatory diseases, the institute said yesterday.

Under the Small Business Innovation Research Fast Track grant program, NIAMS plans to award up to $450,000 in 2014 for two Phase I projects, and it later may provide up to $1.5 million in total costs for each of the projects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.